| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |